ELAB

+ Watchlist + Portfolio

PMGC Holdings Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.56
52-Week Range: $0.55 – $3,091.20
Market Cap: $493.84K
P/E (TTM): —
EPS (TTM): -1993.37
Dividend Yield: —

Advanced Metrics

Price/Book: 0.22
PEG Ratio: —
Return on Equity: -105.22%
Return on Assets: -32.97%
Gross Margin: -20.51%
Operating Margin: -289.98%
Profit Margin: 0.00%
Current Ratio: 1.36
Debt/Equity: 0.85
Total Debt: $14.24M
Free Cash Flow: $-4.45M
Revenue Growth: —
Earnings Growth: —
Enterprise Value: $44.83M

ELAB Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$766.28K	$0.00	$0.00	$590.08K
Cost of Revenue	$318.97K	$578.01K	$0.00	$404.77K
Gross Profit	$447.31K	$1.13M	$0.00	$185.31K
Research & Development	$228.75K	$7.41K	$104.65K	$147.01K
Selling, General & Admin	$1.73M	$1.02M	$3.32M	$5.63M
Operating Expenses	$2.24M	$1.13M	$3.66M	$7.01M
Operating Income	-$1.79M	-$1.13M	-$3.66M	-$6.82M
EBITDA	-$1.79M	-$1.65M	-$3.27M	-$7.40M
Pretax Income	-$1.80M	-$1.66M	-$4.02M	-$7.75M
Income Tax	—	—	$0.00	$30.97K
Net Income	-$1.80M	-$4.30M	-$6.25M	-$7.75M
Diluted EPS	-12246.72	-29262.02	-1195.13	-380.99
Diluted Shares	147	147	5226	20335

ELAB Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$1.15M	$3.33M	$3.98M	$5.40M
Receivables	$12.85K	$3.07K	$5.28K	$340.53K
Inventory	$230.15K	$495.67K	—	$95.10K
Current Assets	$1.55M	$4.92M	$6.05M	$6.87M
Total Assets	$1.89M	$5.19M	$8.99M	$12.87M
Current Liabilities	$588.27K	$1.30M	$1.80M	$3.94M
Long-Term Debt	—	—	—	$85.00K
Total Debt	$283.22K	$210.49K	$0.00	$2.64M
Total Liabilities	$760.87K	$1.36M	$2.33M	$5.03M
Retained Earnings	-$2.72M	-$7.02M	-$13.27M	-$21.02M
Shareholders' Equity	$1.13M	$3.83M	$6.66M	$7.84M
Working Capital	$963.05K	$3.62M	$4.25M	$2.93M

ELAB Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$1.59M	-$4.56M	-$5.49M	-$5.93M
Capital Expenditure	-$35.53K	-$11.19K	-$471.48K	-$448.25K
Free Cash Flow	-$1.62M	-$4.57M	-$5.96M	-$6.38M
Depreciation & Amortisation	$6.51K	$11.65K	$12.95K	$96.66K
Stock-Based Compensation	$171.87K	$487.74K	$97.17K	-$19.16K
Investing Cash Flow	-$32.03K	-$11.19K	-$610.56K	-$2.77M
Financing Cash Flow	$2.36M	$6.74M	$6.76M	$10.12M
Share Repurchases	—	—	$0.00	-$179.00
Net Change in Cash	$744.36K	$2.17M	$659.96K	$1.42M

ELAB Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$0.00	$0.00	$285.95K	$304.14K	$681.99K
Cost of Revenue	$0.00	—	$207.92K	$196.85K	$451.52K
Gross Profit	$0.00	—	$78.03K	$107.28K	$230.47K
Research & Development	$32.43K	$66.67K	$15.00K	$32.90K	$47.06K
Selling, General & Admin	$1.06M	$884.69K	$1.80M	$1.89M	$3.22M
Operating Expenses	$1.20M	$1.01M	$2.27M	$2.52M	$3.55M
Operating Income	-$1.20M	-$1.01M	-$2.19M	-$2.41M	-$3.32M
EBITDA	-$1.57M	-$579.47K	-$2.56M	-$2.68M	-$4.34M
Pretax Income	-$1.58M	-$579.49K	-$2.62M	-$2.97M	-$4.99M
Net Income	-$1.61M	-$562.36K	-$2.59M	-$2.98M	-$4.97M
Diluted EPS	-248.03	-37.97	-117.82	—	-11.18
Diluted Shares	6485	14806	22019	—	444506

ELAB Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$5.36M	$5.68M	$7.70M	$5.40M	$14.35M
Receivables	$52.14K	$204.32K	$369.43K	$340.53K	$542.72K
Inventory	—	—	$128.47K	$95.10K	$253.56K
Current Assets	$6.82M	$7.30M	$9.77M	$6.87M	$16.39M
Total Assets	$8.89M	$9.38M	$14.94M	$12.87M	$26.03M
Current Liabilities	$760.27K	$326.30K	$5.46M	$3.94M	$11.30M
Long-Term Debt	—	—	—	$85.00K	$359.25K
Total Debt	—	—	$4.41M	$2.64M	$7.96M
Total Liabilities	$760.27K	$326.30K	$6.45M	$5.03M	$13.43M
Retained Earnings	-$14.88M	-$15.44M	-$18.03M	-$21.02M	-$25.98M
Shareholders' Equity	$8.13M	$9.05M	$8.49M	$7.84M	$12.61M
Working Capital	$6.06M	$6.98M	$4.31M	$2.93M	$5.09M

ELAB Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$1.35M	-$1.35M	-$1.49M	-$1.75M	-$2.98M
Capital Expenditure	—	—	-$95.59K	-$346.66K	-$363.09K
Free Cash Flow	-$1.35M	-$1.35M	-$1.59M	-$2.10M	-$3.34M
Depreciation & Amortisation	$1.60K	$21.00	$35.28K	$59.76K	$173.90K
Stock-Based Compensation	-$58.84K	$15.84K	$13.18K	$10.66K	$8.22K
Investing Cash Flow	-$215.32K	$196.84K	-$2.20M	-$548.64K	-$2.48M
Financing Cash Flow	$2.94M	$1.47M	$5.71M	-$1.00	$14.41M
Share Repurchases	-$179.00	$0.00	$0.00	$0.00	$0.00
Net Change in Cash	$1.38M	$318.13K	$2.02M	-$2.30M	$8.95M

Market Snapshot

About

PMGC Holdings Inc. operates through its subsidiaries in the healthcare and medical device sectors. The company focuses on developing and commercializing innovative medical technologies and solutions. PMGC Holdings works to bring advanced healthcare products to market through strategic partnerships and research collaborations. The company's business model emphasizes addressing unmet needs in the medical device industry through technology development and market access strategies.